Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Antares is a biotechnology company focused on developing transformational,medicines targeting validated cancer and other serious diseases.
A2 Biotherapeutics develops T cell therapies targeting solid tumors precisely.
Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.
Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.
Halda Therapeutics is a research-stage drug discovery company.
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes.
Remedico is a Mobile healthcare.
Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.
IconOVir Bio is a preclinical-stage biotechnology company developing oncolytic virus therapy for the treatment of patients with cancer.
Locana develops RNA-targeting gene therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.
InnoSkel is a pioneering platform biotechnology company developing therapies for rare skeletal diseases.
Oyster is a clinical stage pharmaceutical company focused on the discovery development & commercialization .
Pact Pharma is a developer of personalized adoptive T cell therapies designed for the eradication of solid tumors.
TargEDys develops functional food, medical food and medical products to harness the microbiota’s ability to regulate appetite.
Vida Ventures has invested in 42 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Vida Ventures's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Biopharma. The firm invests across 16 different industry categories.
Among tracked funding rounds, Tectonic Therapeutic received $185.0M in a Post Ipo Equity round. Vida Ventures's total known invested capital is $4.9B.
Vida Ventures's average investment size is $117.6M across its portfolio of 42 companies.
Recent Vida Ventures portfolio additions include ReCode Therapeutics, Volastra Therapeutics, Antares Therapeutics, A2 Biotherapeutics, Attovia Therapeutics. These companies were founded in 2020 or later.